Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A non-invasive or invasive transitional cell carcinoma characterized by a papillary growth pattern. It may occur in the bladder or the renal pelvis.
Biomarker and diagnostic research for papillary transitional cell carcinoma has been reported in the published literature.
No clinical trials have been registered for papillary transitional cell carcinoma.
64 publications have been identified in PubMed for papillary transitional cell carcinoma. Research spans Basic Science / Preclinical (30%), Case Report / Case Series (22%), and Review / Meta-Analysis (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 19 | 30% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 4:29 PM UTC
Patient case studies
14 |
22% |
Research summaries | 13 | 20% |
Testing and diagnosis research | 11 | 17% |
Disease patterns and progression | 6 | 9% |
Clinical study results | 1 | 2% |
Basar M (2026). [PMID: 41609241](https://pubmed.ncbi.nlm.nih.gov/41609241/). *Adv Anat Pathol*. [Review / Meta-Analysis]
Lopez-Beltran A (2026). [PMID: 41384708](https://pubmed.ncbi.nlm.nih.gov/41384708/). *Histopathology*. [Review / Meta-Analysis]
Petrovic V (2026). [PMID: 41597444](https://pubmed.ncbi.nlm.nih.gov/41597444/). *Medicina (Kaunas)*. [Basic Science / Preclinical]
Pichler R (2026). [PMID: 40716983](https://pubmed.ncbi.nlm.nih.gov/40716983/). *Eur Urol Oncol*. [Basic Science / Preclinical]
De Rose AF (2026). [PMID: 41492217](https://pubmed.ncbi.nlm.nih.gov/41492217/). *Urologia*. [Case Report / Case Series]
Takebe S (2026). [PMID: 42146968](https://pubmed.ncbi.nlm.nih.gov/42146968/). *IJU Case Rep*. [Case Report / Case Series]
Domian N (2026). [PMID: 41692428](https://pubmed.ncbi.nlm.nih.gov/41692428/). *Cancer Med*. [Basic Science / Preclinical]
Li J (2026). [PMID: 41638478](https://pubmed.ncbi.nlm.nih.gov/41638478/). *Cell Mol Gastroenterol Hepatol*. [Epidemiology / Natural History]
Kobayashi G (2026). [PMID: 41686301](https://pubmed.ncbi.nlm.nih.gov/41686301/). *World J Urol*. [Diagnostic / Biomarker]
Aponte-Colon DA (2026). [PMID: 41354277](https://pubmed.ncbi.nlm.nih.gov/41354277/). *Urology*. [Review / Meta-Analysis]